Electrocatalytic overall water splitting based on (ZnNiCoFeY)xOy high-entropy oxide supported on MoS2

Hydrogen energy is a sustainable and clean source that can meet global energy demands without adverse environmental impacts. High-entropy oxides (HEOs), multielement (5 or more) oxides with an equiatomic or near-equatomic elemental composition, offer a novel approach to designing bifunctional electrocatalysts. This work explores (ZnNiCoFeY)xOy over MoS2 as a bifunctional electrocatalyst (HEO–MoS2) in an alkaline medium. The HEO was synthesized using a combustion process and loaded over MoS2 using an ultrasonic method. The synthesized HEO over MoS2 exhibits excellent performance, including long-term stability for over 24 h, an overpotential of 214 mV vs the reversible hydrogen electrode (RHE) for the hydrogen evolution reaction (HER), and 308 mV for the oxygen evolution reaction (OER) at 10 mA cm−2. This bifunctional electrocatalyst exhibits low overpotential for both the HER and the OER at high current densities. Additionally, HEO–MoS2 demonstrates smaller solution and charge transfer resistance values. The electrolyzer was assembled using bifunctional HEO–MoS2 electrodes for overall water splitting. These electrodes exhibited a low cell voltage of 1.65 V at 10 mA cm−2. The novel electrocatalyst was fabricated using a facile and scalable method that appeals to industrial applications

Evidence of in Vivo Existence of Borrelia Biofilm in Borrelial Lymphocytomas

Lyme borreliosis, caused by the spirochete Borrelia burgdorferi sensu lato, has grown into a major public health problem. We recently identified a novel morphological form of B. burgdorferi, called biofilm, a structure that is well known to be highly resistant to antibiotics. However, there is no evidence of the existence of Borrelia biofilm in vivo; therefore, the main goal of this study was to determine the presence of Borrelia biofilm in infected human skin tissues. Archived skin biopsy tissues from borrelial lymphocytomas (BL) were reexamined for the presence of B. burgdorferi sensu lato using Borrelia-specific immunohistochemical staining (IHC), fluorescent in situ hybridization, combined fluorescent in situ hybridization (FISH)—IHC, polymerase chain reaction (PCR), and fluorescent and atomic force microscopy methods. Our morphological and histological analyses showed that significant amounts of Borrelia-positive spirochetes and aggregates exist in the BL tissues. Analyzing structures positive for Borrelia showed that aggregates, but not spirochetes, expressed biofilm markers such as protective layers of different mucopolysaccharides, especially alginate. Atomic force microscopy revealed additional hallmark biofilm features of the Borrelia/alginate-positive aggregates such as inside channels and surface protrusions. In summary, this is the first study that demonstrates the presence of Borrelia biofilm in human infected skin tissues

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

Experimental and first-principles insights into an enhanced performance of Ru-doped copper phosphate electrocatalyst during oxygen evolution reaction

The oxygen evolution reaction (OER) is a vital half-reaction in many applications, such as the electrochemical H2O splitting, CO2, and N2 conversion processes. The OER involves a four-electron transfer and is a kinetically sluggish reaction that requires additional potential to drive. To enhance the electrochemical performance of the above-mentioned applications, highly efficient, corrosion-resistant, earth-abundant, and eco-friendly electrocatalysts are required. Here, we report a highly porous, minimally Ru-doped copper phosphate electrocatalyst obtained through co-precipitation. The optimized electrocatalyst (5% Ru-doped copper phosphate) exhibits a low overpotential of 340 mV to achieve 10 mA cm−2 compared to copper-based materials, and it remains stable over 20 h. The high performance is attributed to a high electrochemically effective surface area (ECSA) of 30.25 cm2, facilitating effective ion transportation at the electrode/electrolyte interface and excellent electrical conductivity. This result is supported by density functional theory calculations, which demonstrate that ruthenium enhances the electrochemical properties by increasing electronic conductivity, reducing the theoretical overpotential, and influencing the rate-determining step of the oxygen evolution reaction. Herein, the electrocatalyst is attractive for commercialization due to its utilization of minimal ruthenium in earth-abundant electrocatalysts, which offer competitive performance

Electrocatalytic overall water splitting based on (ZnNiCoFeY)xOy high-entropy oxide supported on MoS2

Hydrogen energy is a sustainable and clean source that can meet global energy demands without adverse environmental impacts. High-entropy oxides (HEOs), multielement (5 or more) oxides with an equiatomic or near-equatomic elemental composition, offer a novel approach to designing bifunctional electrocatalysts. This work explores (ZnNiCoFeY)xOy over MoS2 as a bifunctional electrocatalyst (HEO–MoS2) in an alkaline medium. The HEO was synthesized using a combustion process and loaded over MoS2 using an ultrasonic method. The synthesized HEO over MoS2 exhibits excellent performance, including long-term stability for over 24 h, an overpotential of 214 mV vs the reversible hydrogen electrode (RHE) for the hydrogen evolution reaction (HER), and 308 mV for the oxygen evolution reaction (OER) at 10 mA cm−2. This bifunctional electrocatalyst exhibits low overpotential for both the HER and the OER at high current densities. Additionally, HEO–MoS2 demonstrates smaller solution and charge transfer resistance values. The electrolyzer was assembled using bifunctional HEO–MoS2 electrodes for overall water splitting. These electrodes exhibited a low cell voltage of 1.65 V at 10 mA cm−2. The novel electrocatalyst was fabricated using a facile and scalable method that appeals to industrial applications